Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.185 USD | +0.71% | +16.90% | +183.75% |
15/05 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
15/05 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+183.75% | 1.06B | |
+9.19% | 114B | |
+11.46% | 104B | |
-12.52% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.85% | 17.89B | |
+8.42% | 14.28B | |
+35.38% | 12.55B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Arcutis Biotherapeutics Launches ZORYVE Topical Foam to Treat Seborrheic Dermatitis